Fig. 2. Analysis of the clinical and proteomic data.
a Top 3 Principal Components show separation of the sample by Acute Kidney Injury (AKI) (stage 2 or 3) case status. b External validation of AKI associated proteins in the discovery cohort shows high correlation with increased risk of AKI with significance of p < 0.05. (n = 62). The black line of regression runs diagonally across, and the gray shaded area represents the region wthin 95% Confidence Intervals around the regression line. c Expression heatmap shows a distinct separation of the cases and controls using the 62 significant proteins identified from the validation cohort in the discovery cohort. Source data for the PCA plots in a are found in the Synapse data repository syn35874390. Source Data for b are provided in Supplementary Data 1(sheet “Table 2”). Source Data for c is from the raw data matrix provided in syn35874390 but filtered for the 62 proteins documented in the sheet “Table 2” in Supplementary Data 1.